{"id":"W2590664415","doi":"10.1016/s0140-6736(17)30069-7","title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":844,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Prediabetes; Liraglutide; Medicine; Placebo; Type 2 diabetes; Diabetes mellitus; Internal medicine; Weight loss; Weight management; Endocrinology; Obesity; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05654559697299896,"score_gpt":0.3162244382012697,"score_spread":0.2596788412282707,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}